Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125395742 | 12539574 | 2 | F | 2015 | 20160719 | 20160708 | 20160803 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-35909BP | BOEHRINGER INGELHEIM | 0.00 | F | Y | 0.00000 | 20160803 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125395742 | 12539574 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 22512 | 150 | MG | CAPSULE | BID | ||||||
| 125395742 | 12539574 | 2 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | Oral | 10 MG | 0 | 70 | MG | TABLET | /wk | ||||||
| 125395742 | 12539574 | 3 | C | GLUCOSAMINE HCL MSM | 2 | Oral | 3000 MG | 0 | 3000 | MG | TABLET | QD | |||||||
| 125395742 | 12539574 | 4 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG | 0 | 25 | MG | TABLET | QD | ||||||
| 125395742 | 12539574 | 5 | C | CALCIUM WITH VITAMIN D | CALCIUMVITAMIN D | 1 | Oral | 600 MG | 0 | 200 | MG | TABLET | TID | ||||||
| 125395742 | 12539574 | 6 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 600 MG | 0 | 600 | MG | TABLET | QD | ||||||
| 125395742 | 12539574 | 7 | C | CHONDROITIN | CHONDROITIN | 1 | Oral | 2400 MG | 0 | 2400 | MG | TABLET | QD | ||||||
| 125395742 | 12539574 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 125395742 | 12539574 | 9 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG | 0 | 12.5 | MG | TABLET | BID | ||||||
| 125395742 | 12539574 | 10 | C | GLUCOSIMIN WITH CHONDROITIN | 2 | Oral | 1200 MG | 0 | 1200 | MG | TABLET | QD | |||||||
| 125395742 | 12539574 | 11 | C | GLUCOSAMIN WITH MSN | 2 | Oral | 4 ANZ | 0 | TABLET | BID | |||||||||
| 125395742 | 12539574 | 12 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 4 ANZ | 0 | TABLET | BID | ||||||||
| 125395742 | 12539574 | 13 | C | CALCIUM | CALCIUM | 1 | Oral | 800 MG | 0 | 800 | MG | TABLET | QD | ||||||
| 125395742 | 12539574 | 14 | C | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 10 MG | 0 | 70 | MG | TABLET | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125395742 | 12539574 | 1 | Atrial fibrillation |
| 125395742 | 12539574 | 2 | Osteoporosis |
| 125395742 | 12539574 | 3 | Product used for unknown indication |
| 125395742 | 12539574 | 4 | Hypertension |
| 125395742 | 12539574 | 5 | Osteoporosis |
| 125395742 | 12539574 | 6 | Product used for unknown indication |
| 125395742 | 12539574 | 7 | Product used for unknown indication |
| 125395742 | 12539574 | 8 | Blood cholesterol increased |
| 125395742 | 12539574 | 9 | Heart rate increased |
| 125395742 | 12539574 | 10 | Arthritis |
| 125395742 | 12539574 | 11 | Arthritis |
| 125395742 | 12539574 | 12 | Arthritis |
| 125395742 | 12539574 | 13 | Arthritis |
| 125395742 | 12539574 | 14 | Bone density abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125395742 | 12539574 | Atrial fibrillation | |
| 125395742 | 12539574 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125395742 | 12539574 | 1 | 201508 | 0 | ||
| 125395742 | 12539574 | 9 | 201510 | 0 |